Multiple diverse protein targets and pathways

The term Multiple diverse protein targets and pathways is a non-specific designation used to describe therapeutic interventions that interact with a broad array of molecular entities rather than a single, defined target. This concept is central to polypharmacology, where drugs are designed or discovered to modulate multiple receptors, enzymes, or signaling cascades to treat complex, multifactorial diseases (Hopkins, 2008, Nature Chemical Biology). While this multi-target approach can enhance efficacy in conditions like cancer or psychiatric disorders by overcoming pathway redundancy, it also increases the risk of off-target interactions and systemic toxicity (Anighoro et al., 2014, Journal of Medicinal Chemistry). In clinical research and drug databases, this phrase often serves as a placeholder for agents whose precise molecular interactome is either intentionally broad or not yet fully characterized (Guimaraes et al., 2014, Briefings in Bioinformatics). Consequently, it does not represent a single biological target but a collective pharmacological profile that presents unique challenges for drug development and safety monitoring.

Other names

PolypharmacologyMulti-targetPleiotropic targetsNetwork pharmacology

Simultaneous modulation of multiple distinct molecular targets and signaling cascades.